4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tenax Therapeutics, Inc. (TENX) operates in the Biotechnology industry and is headquartered in Chapel Hill, United States with about 14 employees. Its market capitalization is roughly $486 million. In the fiscal year ended 2025-12-31, TENX reported $0M in revenue and ($53M) in net income.
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($56M) | ($20M) | ($8M) | ($11M) | — |
| Net Income | ($53M) | ($18M) | ($8M) | ($11M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($17M) | ($16M) | ($17M) | ($12M) | ($11M) | — |
| Net Income | ($16M) | ($16M) | ($16M) | ($11M) | ($10M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $104M | $97M | $12M | $3M | — |
| Total Liabilities | $7M | $5M | $4M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TENX viewer.
About TickerBase · Data methodology & sources